- Home
- LTRN vs DARE Comparison
LTRN vs DARE Comparison
Compare LTRN & DARE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LTRN
- DARE
- Stock Information
- Founded
- LTRN 2013
- DARE N/A
- Country
- LTRN United States
- DARE United States
- Employees
- LTRN N/A
- DARE N/A
- Industry
- LTRN Biotechnology: Pharmaceutical Preparations
- DARE Biotechnology: Pharmaceutical Preparations
- Sector
- LTRN Health Care
- DARE Health Care
- Exchange
- LTRN Nasdaq
- DARE Nasdaq
- Market Cap
- LTRN 33.7M
- DARE 31.9M
- IPO Year
- LTRN 2020
- DARE N/A
- Fundamental
- Price
- LTRN $4.48
- DARE $3.28
- Analyst Decision
- LTRN Hold
- DARE Strong Buy
- Analyst Count
- LTRN 1
- DARE 4
- Target Price
- LTRN N/A
- DARE $20.33
- AVG Volume (30 Days)
- LTRN 69.9K
- DARE 35.1K
- Earning Date
- LTRN 03-17-2025
- DARE 11-14-2024
- Dividend Yield
- LTRN N/A
- DARE N/A
- EPS Growth
- LTRN N/A
- DARE N/A
- EPS
- LTRN N/A
- DARE N/A
- Revenue
- LTRN N/A
- DARE $1,881,316.00
- Revenue This Year
- LTRN N/A
- DARE N/A
- Revenue Next Year
- LTRN N/A
- DARE $136.52
- P/E Ratio
- LTRN N/A
- DARE N/A
- Revenue Growth
- LTRN N/A
- DARE 88.13
- 52 Week Low
- LTRN $2.79
- DARE $2.67
- 52 Week High
- LTRN $11.99
- DARE $7.56
- Technical
- Relative Strength Index (RSI)
- LTRN 66.50
- DARE 49.54
- Support Level
- LTRN $3.48
- DARE $3.03
- Resistance Level
- LTRN $3.97
- DARE $3.38
- Average True Range (ATR)
- LTRN 0.44
- DARE 0.12
- MACD
- LTRN 0.06
- DARE 0.01
- Stochastic Oscillator
- LTRN 76.50
- DARE 71.43
About LTRN Lantern Pharma Inc.
Lantern Pharma Inc is an AI company transforming the cost, pace, and timeline of oncology drug discovery and development. Its proprietary AI and machine learning (ML) platform, RADR, uses oncology-focused data points and advanced ML algorithms to solve billion-dollar, real-world problems in cancer drug development. The group's growing pipeline of precision therapies has been accelerated using AI and input from world-class scientific advisors and collaborators.
About DARE Dare Bioscience Inc.
Dare Bioscience Inc is a biopharmaceutical company committed to advancing innovative products for women's health. The company identifies, develops and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in advanced clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.